Home > Cashflow Statement > DIVIS LABORATORIES

DIVIS LABORATORIES
Cash Flow from Financing Activities

    Back to Cashflow Statement
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
AD     Remove this Ad

DIVIS LABORATORIES Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹-799 Cr₹-799 Cr₹-797 Cr₹-532 Cr₹-35 Cr

What is the latest Cash Flow from Financing Activities ratio of DIVIS LABORATORIES ?

The latest Cash Flow from Financing Activities ratio of DIVIS LABORATORIES is ₹-799 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-799 Cr
Mar2024₹-799 Cr
Mar2023₹-797 Cr
Mar2022₹-532 Cr
Mar2021₹-35 Cr

How is Cash Flow from Financing Activities of DIVIS LABORATORIES Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-799 Cr
Negative
Mar2024 ₹-799 Cr
Negative
Mar2023 ₹-797 Cr
Negative
Mar2022 ₹-532 Cr
Negative
Mar2021 ₹-35 Cr -

Compare Cash Flow from Financing Activities of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹159,193.8 Cr -1.7% -4.1% 3.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,837.0 Cr 1% 3.8% 0.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,394.0 Cr -0% -3% 33.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,999.0 Cr -1.3% -1.3% 8.6% Stock Analytics
CIPLA ₹100,379.0 Cr -1.1% -6.3% -18.3% Stock Analytics
MANKIND PHARMA ₹84,227.3 Cr 2% -0.6% -16.4% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

-1.7%

-4.1%

3.8%

SENSEX

-0.8%

-11.7%

-3.6%


You may also like the below Video Courses